Boston Scientific (BSX) Net Income (QoQ) (2009 - 2026)
Boston Scientific (BSX) Net Income (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn |
| 10 | Steris | 21.53 Bn | 21.09 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.70% |
| Dec 31, 2025 | -11.38% |
| Sep 30, 2025 | -4.91% |
| Jun 30, 2025 | 18.30% |
| Mar 31, 2025 | 19.57% |
| Dec 31, 2024 | 19.83% |
| Sep 30, 2024 | 45.65% |
| Jun 30, 2024 | -34.69% |
| Mar 31, 2024 | -2.18% |
| Dec 31, 2023 | -0.20% |
| Sep 30, 2023 | 87.04% |
| Jun 30, 2023 | -13.74% |
| Mar 31, 2023 | 121.99% |
| Dec 31, 2022 | -25.00% |
| Sep 30, 2022 | -27.69% |
| Jun 30, 2022 | 134.23% |
| Mar 31, 2022 | 19.35% |
| Dec 31, 2021 | -77.80% |
| Sep 30, 2021 | 125.27% |
| Jun 30, 2021 | -45.45% |